Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasms
×
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
×
Clear all
Filters
3
NCT04034355
2022-01-26
POLAR-A
Egetis Therapeutics
Phase 3
Terminated
301 enrolled
18 charts
NCT03654729
2021-12-17
POLAR-M
Egetis Therapeutics
Phase 3
Terminated
291 enrolled
20 charts